On July 16, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) designated Jason Rickard, 50, the Company’s Senior Vice President, Chief Operating Officer, as the Company’s principal financial officer, and Ronald Silver, 39, the Company’s Corporate Controller, as the Company’s principal accounting officer, in each case, effective immediately.
On July 16, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) designated Jason Rickard, 50, the Company’s Senior Vice President, Chief Operating Officer, as the Company’s principal financial officer, and Ronald Silver, 39, the Company’s Corporate Controller, as the Company’s principal accounting officer, in each case, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Jason Rickard was appointed as Principal Financial Officer at IRONWOOD PHARMACEUTICALS INC.
Action
designated
Role
Principal Financial Officer
Exact text from the filing
On July 16, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) designated Jason Rickard, 50, the Company’s Senior Vice President, Chief Operating Officer, as the Company’s principal financial officer, and Ronald Silver, 39, the Company’s Corporate Controller, as the Company’s principal accounting officer, in each case, effective immediately.
Ronald Silver was appointed as Principal Accounting Officer at IRONWOOD PHARMACEUTICALS INC.
Action
designated
Role
Principal Accounting Officer
Exact text from the filing
On July 16, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) designated Jason Rickard, 50, the Company’s Senior Vice President, Chief Operating Officer, as the Company’s principal financial officer, and Ronald Silver, 39, the Company’s Corporate Controller, as the Company’s principal accounting officer, in each case, effective immediately.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.